Myung-Ho Kim
Overview
Explore the profile of Myung-Ho Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu M, Alwahsh S, Kim M, Kollmar O
Transpl Int
. 2024 Dec;
37:13557.
PMID: 39726675
The scarcity of donors has prompted the growing utilization of steatotic livers, which are susceptible to injuries following orthotopic liver transplantation (OLT). This study aims to assess the efficacy of...
2.
Lee M, Kim M
J Pharmacopuncture
. 2024 Jul;
27(2):142-153.
PMID: 38948313
Objectives: This study aimed to analyze the educational needs of interns and residents in Korean medicine as the first step in developing an education program to improve their research competencies....
3.
Kim M, Ahn S, Hur N, Oh S, Son C
Front Pharmacol
. 2024 Mar;
15:1362391.
PMID: 38464716
Non-alcoholic fatty liver disease (NAFLD) is difficult to manage because of its complex pathophysiological mechanism. There is still no effective treatment other than lifestyle modification (LM) such as dietary modifications,...
4.
Kim K, Kim M, Kang J, Baek J, Jeon B, Kim H, et al.
J Ginseng Res
. 2024 Jan;
48(1):89-97.
PMID: 38223828
Background: Ginsenoside F2 (GF2), the protopanaxadiol-type constituent in , has been reported to attenuate metabolic dysfunction-associated steatotic liver disease (MASLD). However, the mechanism of action is not fully understood. Here,...
5.
Kim M, Elbaz J, Jilg N, Gustafson J, Xu M, Hatipoglu D, et al.
Front Med (Lausanne)
. 2023 Mar;
10:1095828.
PMID: 36910479
Background: This study aimed to investigate the efficacy and safety of subcutaneous injection of peginterferon lambda in patients hospitalized with COVID-19. Methods: In this study (NCT04343976), patients admitted to hospital...
6.
Kim M, Sise M, Xu M, Goldberg D, Fontana R, Kort J, et al.
Clin Transplant
. 2023 Feb;
37(4):e14926.
PMID: 36752566
Our previous Multicenter Trial to Transplant HCV-infected Kidneys (MYTHIC) observed that 100% of hepatitis C virus (HCV)-uninfected patients who received a kidney from an HCV-infected deceased donor were cured of...
7.
Park W, Song G, Boo M, Kim H, Park J, Jung S, et al.
Antioxidants (Basel)
. 2023 Jan;
12(1).
PMID: 36670911
Obesity is a burden to global health. Non-shivering thermogenesis of brown adipose tissue (BAT) and white adipose tissue (WAT) is a novel strategy for obesity treatment. Anmyungambi (AMGB) decoction is...
8.
Kim H, Shim Y, Choi S, Kim M, Lee G, You H, et al.
Exp Mol Med
. 2023 Jan;
55(1):158-170.
PMID: 36631664
Chronic alcohol consumption often induces hepatic steatosis but rarely causes severe inflammation in Kupffer cells (KCs) despite the increased hepatic influx of lipopolysaccharide (LPS), suggesting the presence of a veiled...
9.
Kim M, Kim M, Salloum S, Qian T, Wong L, Xu M, et al.
Hepatol Commun
. 2022 Jun;
6(9):2581-2593.
PMID: 35712812
Lipophilic but not hydrophilic statins have been shown to be associated with reduced risk for hepatocellular carcinoma (HCC) in patients with chronic viral hepatitis. We investigated differential actions of lipophilic...
10.
Kim M, Salloum S, Wang J, Wong L, Regan J, Lefteri K, et al.
J Infect Dis
. 2021 Sep;
224(5):777-782.
PMID: 34467988
We analyzed plasma levels of interferons (IFNs) and cytokines, and expression of IFN-stimulated genes in peripheral blood mononuclear cells in patients with coronavirus disease 2019 of varying disease severity. Patients...